# Survanta

NDC: 0074-1040
Generic name: Beractant
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: ENDOTRACHEAL
Marketing started: 19910701

FDA application: BLA020032

## Active ingredients

- BERACTANT: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-1040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-1040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ef9e3a5-fc39-4ae1-0dad-6b47a1684635